1-3 of 3
James Froehlich
Close
Sort by
Journal Articles

A Comparison of Bleeding Events Among Patients on Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism

Jordan K Schaefer, Josh Errickson, Xiaowen Kong, Mona A Ali, Naina Chipalkatti, Brian Haymart, Scott Kaatz, Gregory D Krol, Suman L Sood, James Froehlich, Geoffrey D. Barnes
Journal: Blood
Blood (2023) 142 (Supplement 1): 135.
https://doi.org/10.1182/blood-2023-184457
Published: 2023
Journal Articles

Outcomes of Oral Anticoagulation with Concomitant NSAID Use: A Registry Based Cohort Study

Jordan K Schaefer, Josh Errickson, Xiaowen Kong, Mona A Ali, Naina Chipalkatti, Paul Dorby, Christopher Giuliano, Brian Haymart, Scott Kaatz, Jacob E Kurlander, Gregory D Krol, Sahana Shankar, Suman L Sood, James Froehlich, Geoffrey D. Barnes
Journal: Blood
Blood (2023) 142 (Supplement 1): 5129.
https://doi.org/10.1182/blood-2023-184907
Published: 2023
Journal Articles

First in Human Phase 1 Single Dose Escalation Studies of the E-Selectin Antagonist GMI-1271 Show a Favorable Safety, Pharmacokinetic, and Biomarker Profile

Sumana Devata, MD, Suman L. Sood, MD, Martina V Hemmer, MA, Henry Flanner, MS, William Kramer, PhD, Christine Nietubicz, Angela Hawley, Dana E Angelini, MD, Daniel Durant Myers, DVM, MPH, Susan Blackburn, James Froehlich, MD, Thomas W. Wakefield, MD, John L. Magnani, PhD, Helen M. Thackray, MD
Journal: Blood
Blood (2015) 126 (23): 1004.
https://doi.org/10.1182/blood.V126.23.1004.1004
Published: 2015